Intra-Cellular Therapies | 10-Q:季度报表
Intra-Cellular Therapies | 8-K:细胞内疗法公布2024年第一季度财务业绩
Intra-Cellular Therapies | ARS:年度报告
Intra-Cellular Therapies | DEFA14A:其他
Intra-Cellular Therapies | DEF 14A:股东委托书决议
Intra-Cellular Therapies | 4:持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 424B5:募资说明书
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 424B5:募资说明书
Intra-Cellular Therapies | S-3ASR:“知名成熟发行人”证券注册声明
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 4:持股变动声明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4:持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 4:持股变动声明-董事 RIGGS RORY B
Intra-Cellular Therapies | 8-K:重大事件
Intra-Cellular Therapies | 4:持股变动声明-高管 Mates Sharon
Intra-Cellular Therapies | 4:持股变动声明-高管 Hineline Lawrence J.
暂无数据